Broadline Capital

Broadline Capital is the famous VC, which was founded in 2005. The company was established in North America in United States. The main office of represented VC is situated in the New York.

Comparing to the other companies, this Broadline Capital performs on 12 percentage points less the average number of lead investments. The high activity for fund was in 2011. The common things for fund are deals in the range of 10 - 50 millions dollars. The fund is generally included in less than 2 deals every year. The higher amount of exits for fund were in 2017. When the investment is from Broadline Capital the average startup value is 100-500 millions dollars. The real fund results show that this VC is 30 percentage points more often commits exit comparing to other companies.

The fund has specific favorite in a number of founders of portfolio startups. Among the most popular portfolio startups of the fund, we may highlight EndoSphere Inc., China Rapid Finance, Powermers Inc.. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. We can highlight the next thriving fund investment areas, such as Medical Device, Life Science.

The current fund was established by Chris Thorne. The overall number of key employees were 6.

The usual cause for the fund is to invest in rounds with 2-3 partakers. Despite the Broadline Capital, startups are often financed by Northwater Capital, Rev1 Ventures, Queen City Angels. The meaningful sponsors for the fund in investment in the same round are Rev1 Ventures, Northwater Capital, Queen City Angels. In the next rounds fund is usually obtained by Rev1 Ventures, QED Investors, Ohio Department of Development.

Notable deals

Review

• No reviews are submitted yet.